$RXRX Income Statement | Understand Stock

$RXRX

$4.05 +$0.25 (6.58%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Operating revenue
Grant revenue
Total revenue
Operating costs and expenses
Cost of revenue
Research and development
General and administrative
Total operating expenses
Total operating costs and expenses

Loss from operations
Other income, net
Loss before income tax benefit
Income tax benefit
Net loss
Per share data
Net loss per share of class A, B and exchangeable common stock, basic (in dollars per share)
Net loss per share of class A, B and exchangeable common stock, diluted (in dollars per share)
Weighted-average shares (Class A, B and Exchangeable) outstanding, basic (in shares)
Weighted-average shares (Class A, B and Exchangeable) outstanding, diluted (in shares)

Comments